SCREENING OF CELIAC DISEASE IN SCHOLAR CHILDREN IN ITALY
NCT ID: NCT04867863
Last Updated: 2021-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
4570 participants
OBSERVATIONAL
2015-05-31
2018-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multicenter Study on the Toxicity of Gluten Traces in the Treatment of Celiac Disease
NCT00250146
Validation of a New Innovative Method for Specific Marker Detection in Celiac Disease
NCT06324539
Dietary Assessment and Mycotoxin Exposure in Celiac Disease
NCT01975155
Risk of Celiac Disease and Age at Gluten Introduction
NCT00639444
Characteristics of Anemia in Celiac Disease
NCT05172895
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. HLA DQ2/DQ8 genotyping (by a rapid test)
2. In children genetically predisposed to CD serological investigations will be performed (both IgA TTG and IgG DGP antibodies)
3. The overall population will be evaluated for the prevalence and severity of dental caries (by using the DMFT/dmft index)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
5 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
FONDAZIONE CARIVERONA
UNKNOWN
Azienda ULSS di Verona e Provincia
OTHER
Università Politecnica delle Marche
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carlo Catassi, M.D.
PROFESSOR OF PEDIATRICS AND HEAD OF THE DEPARTMENT OF PEDIATRICS, UNIVERSITA POLITECNICA DELLE MARCHE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Pediatrics Universita' Politecnica Delle Marche
Ancona, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
121CELIA14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.